INO
Inovio Pharmaceuticals Inc
1.20$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -32.1% | +21.9% | +96.7% | -87.0% | +232.3% | -82.6% | +1,498.3% | -91.8% | +25.1% | +13.1% | -95.2% | +538.9% | -67.8% | +374.9% | -79.9% | -11.6% | +2,262.9% | -93.3% | -26.5% | +6.9% | +187.7% | -76.3% | +294.0% | +1,067.0% | -98.6% | -7.8% | +96.6% | +71.9% | -73.6% | -100.0% | – | -100.0% | – | -44.1% | -100.0% | – | – | – | – | – | |
| – | -11.4% | +2.6% | -2.7% | +6.8% | -3.4% | -0.3% | -8.6% | -2.7% | +20.7% | -7.5% | -7.8% | -14.9% | +5.1% | -4.9% | +17.1% | +18.2% | -0.6% | +48.4% | +81.4% | -33.5% | -97.1% | +3,958.8% | -97.5% | -3.4% | -1.0% | -14.6% | -0.8% | -9.7% | -83.0% | +333.6% | +9.1% | -7.6% | +1.3% | – | – | +1.1% | +0.6% | -1.1% | – | – | |
| – | – | – | – | – | – | – | – | -1,099.5% | – | – | – | – | – | – | -1,765.8% | – | -8,873.9% | – | -26.5% | +6.9% | -285.1% | – | +294.0% | +1,067.0% | -113.4% | – | – | +71.9% | -118.7% | – | – | – | – | – | -1,235.0% | – | – | – | – | – | |
| – | -11.4% | +2.6% | -2.7% | +6.8% | -3.4% | -0.3% | -8.6% | -2.7% | +20.7% | -7.5% | -7.8% | -14.9% | +15.0% | -13.1% | +17.1% | +18.2% | -0.6% | +48.4% | +81.4% | -33.5% | +96.0% | -39.4% | +0.9% | -41.4% | +27.3% | -28.4% | -21.3% | -34.7% | +11.3% | +21.2% | +10.4% | -18.9% | -31.2% | +124,776.5% | -99.9% | -5.9% | -23.0% | +34.0% | -21.3% | – | |
| – | +21.0% | +11.5% | -20.6% | +2.4% | +27.1% | +20.7% | -25.9% | -5.5% | -17.0% | +23.8% | -16.1% | -2.9% | +53.1% | -14.4% | +48.6% | -8.7% | -14.8% | +61.1% | -8.8% | +3.9% | +6.8% | +13.6% | +203.7% | -75.6% | +18.0% | -0.4% | -2.6% | -26.6% | +3.2% | +3.2% | +96,452.0% | -15.6% | -99.9% | +118,632.3% | -5.1% | -99.9% | -8.4% | +109,109.8% | -99.9% | – | |
| – | -5.7% | +4.6% | -7.0% | +5.9% | +2.7% | +4.9% | -13.5% | -3.4% | +11.7% | -2.0% | -9.7% | -12.4% | +23.7% | -13.5% | +25.9% | +9.3% | -4.5% | +51.6% | +57.7% | -27.8% | +74.2% | -31.5% | +45.9% | -57.2% | +21.8% | -21.6% | -13.2% | -3.6% | -24.0% | +15.2% | +3.1% | -15.8% | -27.9% | +127,322.4% | -99.9% | -5.1% | -21.2% | +26.8% | -12.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +586.4% | -70.2% | -86.4% | +3,060.0% | -72.1% | +76.4% | -41.1% | +13.3% | +112.8% | -78.4% | +193.8% | +10.7% | +9.9% | +5.1% | +1.5% | -30.3% | -46.2% | -52.0% | -9.0% | +2.1% | +0.8% | -34.7% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -9.9% | -37.0% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -216.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -622.8% | – | – | |
| – | +474.7% | -67.9% | -84.9% | +2,803.3% | -187.5% | – | -45.8% | -257.8% | – | -101.8% | – | – | – | – | +430.8% | -131.7% | – | – | -110.6% | – | +351.6% | +240.7% | -43.4% | -53.8% | -252.5% | – | – | – | – | +23,881,700.0% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -227.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -622.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -181.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -519.1% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.